Literature DB >> 22701025

Pyrexia of unknown origin and pulmonary fibrosis as a presentation of MPO-ANCA associated vasculitis.

O Shields1, A Shah, B Mann.   

Abstract

The authors report the case of a 72-year-old man presenting with chronic dyspnoea and pyrexia of unknown origin (PUO). After extensive investigation, he was found to have pulmonary fibrosis with usual interstitial pneumonia pattern on high-resolution CT imaging and positive myeloperoxidase antineutrophil cytoplasmic antibodies (MPO-ANCA) with no infectious cause or other evidence of vasculitis organ involvement. His pyrexia and symptoms settled with oral systemic corticosteroid treatment. To the authors' knowledge this is the first case of MPO-ANCA positive vasculitis presenting as PUO and pulmonary fibrosis alone. The authors review the recent literature regarding the association of pulmonary fibrosis with ANCA-positive vasculitides with regards to pathogenesis, prognosis and treatment.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22701025      PMCID: PMC3079516          DOI: 10.1136/bcr.01.2011.3692

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  18 in total

1.  Pulmonary interstitial fibrosis as a presenting manifestation in perinuclear antineutrophilic cytoplasmic antibody microscopic polyangiitis.

Authors:  Gregg M Eschun; Steven N Mink; Sat Sharma
Journal:  Chest       Date:  2003-01       Impact factor: 9.410

2.  Fever of unknown origin: discrimination between infectious and non-infectious causes.

Authors:  Stamatis P Efstathiou; Angelos V Pefanis; Aphrodite G Tsiakou; Irini I Skeva; Dimitrios I Tsioulos; Apostolos D Achimastos; Theodore D Mountokalakis
Journal:  Eur J Intern Med       Date:  2009-12-06       Impact factor: 4.487

3.  MPO-ANCA-associated small vessel vasculitis presenting as fever of unknown origin. Report of one case.

Authors:  Harun Akar; Cigdem Ozbasli-Levi; Taskin Senturk; Gurhan Kadikoylu; Edi Levi; Zahit Bolaman
Journal:  Nephron       Date:  2002       Impact factor: 2.847

4.  A comparison of the clinical features of ANCA-positive and ANCA-negative idiopathic pulmonary fibrosis patients.

Authors:  Tomoko Nozu; Mitsuko Kondo; Kazuo Suzuki; Jun Tamaoki; Atsushi Nagai
Journal:  Respiration       Date:  2008-12-11       Impact factor: 3.580

Review 5.  Pulmonary fibrosis associated with ANCA-positive vasculitides. Retrospective study of 12 cases and review of the literature.

Authors:  B Hervier; C Pagnoux; C Agard; J Haroche; Z Amoura; L Guillevin; M A Hamidou
Journal:  Ann Rheum Dis       Date:  2008-10-28       Impact factor: 19.103

Review 6.  Clinical and immunological features of drug-induced and infection-induced proteinase 3-antineutrophil cytoplasmic antibodies and myeloperoxidase-antineutrophil cytoplasmic antibodies and vasculitis.

Authors:  Elena Csernok; Peter Lamprecht; Wolfgang L Gross
Journal:  Curr Opin Rheumatol       Date:  2010-01       Impact factor: 5.006

7.  Prevalence and outcome of pulmonary fibrosis in microscopic polyangiitis.

Authors:  G E Tzelepis; M Kokosi; A Tzioufas; S P Toya; K A Boki; A Zormpala; H M Moutsopoulos
Journal:  Eur Respir J       Date:  2009-11-19       Impact factor: 16.671

8.  ANCA-associated lung fibrosis: analysis of 17 patients.

Authors:  Guillaume Foulon; Philippe Delaval; Dominique Valeyre; Benoît Wallaert; Marie-Pierre Debray; Michel Brauner; Pascale Nicaise; Jacques Cadranel; Vincent Cottin; Abdellatif Tazi; Michel Aubier; Bruno Crestani
Journal:  Respir Med       Date:  2008-07-18       Impact factor: 3.415

Review 9.  Review article: Progress of treatment in ANCA-associated vasculitis.

Authors:  David Jayne
Journal:  Nephrology (Carlton)       Date:  2009-02       Impact factor: 2.506

10.  [Prevalence of myeloperoxidase-anti-neutrophil cytoplasmic antibody (MPO-ANCA) in patients with interstitial pneumonia].

Authors:  Akira Shiraki; Morihide Ando; Joe Shindoh; Takashi Abe; Keiko Wakahara; Yasushi Makino; Toshiaki Asano; Harunori Nakashima; Tetsunari Hase; Kikuo Shigemitsu; Michiaki Horiba; Kaoru Shimokata
Journal:  Nihon Kokyuki Gakkai Zasshi       Date:  2007-12
View more
  2 in total

Review 1.  Interstital lung disease in ANCA vasculitis.

Authors:  Marco A Alba; Luis Felipe Flores-Suárez; Ashley G Henderson; Hong Xiao; Peiqi Hu; Patrick H Nachman; Ronald J Falk; J Charles Jennette
Journal:  Autoimmun Rev       Date:  2017-05-04       Impact factor: 9.754

2.  Antineutrophil cytoplasmic antibody-positive conversion and microscopic polyangiitis development in patients with idiopathic pulmonary fibrosis.

Authors:  Naho Kagiyama; Noboru Takayanagi; Tetsu Kanauchi; Takashi Ishiguro; Tsutomu Yanagisawa; Yutaka Sugita
Journal:  BMJ Open Respir Res       Date:  2015-01-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.